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ABSTRACT 
The authors experienced three cases of the resistance to the nondepolarizing neuromuscular blocking agents 
(NMBAs), rocuronium. There are many factors that affect NMBAs such as steroid, endocrine or autoimmune 
diseases which are thyroid disease, parathyroid disease, myasthenia gravis and etc., and anticonvulsant medication. 
However, in these three cases, the patients did not have any neuromuscular disorder, except certain drug 
administration, smoking, endocrine disorder and fever. In this study, we report three cases of the resistance to 
rocuronium where the resistance duration was much shorter than known and we should be aware of the importance 
of neuromuscular monitoring. 
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INTRODUCTION  
In the anesthetic management for the operation, the 
neuromuscular blocking agents are important 
medications that are useful for the endotracheal 
intubation and the improvement of the surgical view. 
Therefore, selecting appropriate neuromuscular 
blocking agents and monitoring the neuromuscular 
function to achieve adequate action time according to 
the operation time would allow efficient maintenance 
of the anesthetic management. The duration of action 
of the neuromuscular blocking agents is affected by the 
shape, type, and blood flow of the muscles, and there is 
a large difference depending on the muscles. In 
particular, expression and duration of the action in the 
diaphragm and the adductor pollicis muscle differ. [1] It 
will also be affected by the "up and down regulation" 
of the nicotinic acetylcholine receptor, which is the site 
of action of the neuromuscular blocking agents, and the 
long-term administration of anticonvulsants and 
hormones for endocrine disorders or steroids. [2-4]  
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Resistance to the neuromuscular blocking agents can 
be explained as a delayed onset time, an incomplete 
muscle relaxation or early recovery of neuromuscular 
blocks, despite enough dose of neuromuscular blocking 
agents.[5] 
Along with the literature review, the authors report 
cases where the patients suspected of such change had 
very short action time.  
 
CASE REPORTS 
Case 1 
A 67-year-old male patient (height: 167 cm; weight 
60.8 kg) was admitted for posterior lumbar interbody 
fusion with bone graft due to spinal stenosis lumbar 3–
5. The patient had a history of benign prostate 
hypertrophy with 5mg of terazosin and lumbar pain 
with non-steroid anti-inflammatory drugs. He had a 30-
year history of smoking (1/2 ~ 3/4 pack/day) and 
alcohol consumption (3–4 times/weak, 1 bottle of 
soju).No abnormal findings was found in the results of 
preoperative complete blood cell count, kidney 
function test, electrolyte and coagulation test (Table 
1).No specific findings was found on chest X-ray and 
electrocardiography(ECG).  The patient entered the 
operation room without premedication and was 
monitored with non-invasive blood pressure(NIBP), 
ECG and oxygen saturation(SpO2). Sixty mg of 
lidocaine and 100mg of propofol were injected for 
general anesthesia. After confirming that the eyelash 
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reflex was absent, assisted ventilation was initiated 
with mask ventilation. Once assisted ventilation was 
stable, N2O/O2 2 L/min (FiO2 0.5) + desflurane 12.0 
volume% was given using 1:1:12 technique. Then 
50mg (0.82 mg/kg) of rocuronium was administered 
after confirming that the patient is stable. In 3 minutes, 
the patient was intubated. Anesthesia was maintained 
with N2O/O2 2 L/min (FiO2 0.5) + desflurane 5.0–8.0 
volume%. After checking the modified Allen’s test on 
the left hand to confirm the collateral circulation of 
hand, an arterial catheter was inserted at left radial 
artery for continuous blood pressure monitoring and an 
18-guage intravenous line was inserted in right 
antecubital vein with plasmalyte A. After inducing 
general anesthesia, the patient was laid in a prone 
position for the spinal surgery. Thirty minutes after the 
start of surgery (1 hour after prone position), the blood 
pressure was dropped below 80–85 mmHg for systolic 
pressure/50–60mmHg for diastolic pressure. To 
increase the blood pressure, 10mg of ephedrine was 
administered 3 times for every 10 minutes, but there 
was no effective response. One hundred μg of 
phenylephrine was administered 5 times for every 10 
minutes, but there was still no effective response. 
Intravenous line was checked for adequate fluid 
infusion and there was no problem.  Norepinephrine 
was continuously administered at 0.05–0.2 μg/kg/min 
to maintain stable blood pressure, and blood pressure 
was maintained with systolic pressure of 85–110 
mmHg / diastolic pressure of 50–70 mmHg. Through 
this process, SpO2was temporarily dropped to 90%. 
IncreasingFiO2to 70% resulted in the gradual recovery 
of SpO2 upto 95%. As there were no other abnormal 
signs, no further management was provided, and FiO2 
was changed to 50% (Table 2).During the above 
process, the changes in spontaneous respiration were 
observed in the capnography, 40 minutes after the first 
administration of rocuronium, and 30mg of rocuronium 
was administered. But the same changes in 
spontaneous respiration were observed in the 
capnography after 10 minutes, and 20mg of 
rocuronium was administered additionally. After that, 
30 mg of rocuronium was administered 3times at the 
intervals of 20–30 minutes. One hundred ninety mg of 
rocuronium was administered in total during 2 hours 
and 40 minutes of the operation duration. At the end of 
the operation, no additional rocuronium was 
administered. When the operation was finished, the 
patient was laid in supine position and all anesthetic 
medications were stopped. While ventilating with 
100% oxygen, the patient was allowed to recover the 
responsiveness to the verbal instruction, such as 
opening his eyes and mouth and taking deep breath. 
Then, 120 mg (2 mg/kg) of sugammadex was 
administered and the endotracheal intubation was 
removed after 3 minutes. The patient was moved to the 
post anesthetic care unit (PACU) after 10 minutes and 
transferred to the general ward after an hour. The 
operation duration was 2 hours and 30 minutes, and the 
anesthetic duration was 3 hours and 20 minutes. During 
the operation, the operation room temperature was 22–
23℃, the patient’s esophageal body temperature was 
maintained at 35.5–37.0℃, and the end-tidal carbon 
dioxide(EtCO2) was maintained at 30–35 mmHg, the 
fluids of 700ml Ringer’s lactate and 800ml plasmalyte 
A were administered, hemoglobin was maintained 
13.8mg/dl, and no transfusion was given as the 
estimated blood loss was below 400ml.  
 
Case 2 
A 27-year-old female patient (height: 160.2 cm; 
weight: 61.9 kg) was admitted for grave’s disease and 
scheduled for the total thyroidectomy. The patient was 
at 26 +1 week’s gestation. She was diagnosed with 
grave’s disease in February2014 and has been 
administering 10mg of methimazole. In January, 2018, 
the thyroid hormone level was not stably controlled, so 
the medication was increased from 10 mg to 40mg of 
methimazole. However, the thyroid hormone level was 
still not controlled and the medication was changed to 
400 mg of propylthiouracil. In August 2018, the free 
T4 level fell within the normal range, so the medication 
was adjusted from 400 mg of propylthiouracil to 30mg 
of methimazole.  In the previous 2 months of the 
operation, the thyroid function test was maintained 
with normal range [Table 3]. There was no unusual 
medical history and there were no abnormal findings in 
the results of preoperative complete blood cell count, 
kidney function test, electrolyte test, and coagulation 
test [Table 1].The patient entered the operation room 
without premedication and was monitored with NIBP, 
ECG and SpO2. Pre-oxygenation with 100% 
oxygen(flow rate : 10L/min) was applied for 2 minutes. 
Sixty mg of lidocaine and 100mg of propofol were 
injected for general anesthesia with rocuronium 50 
mg(0.81 mg/kg) as a muscle relaxant for endotracheal 
intubation. The patient was intubated after performing 
3 minutes of manually controlled ventilation. The 
anesthesia was maintained with Air/O2 2.5L/min (FiO2 
0.4) + sevoflurane 2.0–3.0 volume%. After induction 
of the general anesthesia, skin preparation and surgical 
drape were done for the operation and the operation 
was started. Thirty minutes after the induction of 
general anesthesia, a diaphragm movement(hiccup) 
was observed in the capnography, indicating a 
spontaneous respiration, so 10mg of rocuronium was 
administered. However, after 10 minutes, the changes 
in the spontaneous respiration were observed again in 
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the capnography, and 10mg of rocuronium was 
administered. After another 10 minutes, a diaphragm 
movement was observed and capnography revealed 
spontaneous respiration, so bolus dose of rocuronium 
was increased to 20 mg. After that, 10 mg of 
rocuronium was administered at the intervals of 10–15 
minutes. One hundred twenty mg of rocuronium was 
administered in total over 2 hours. During the 
operation, the systolic pressure was maintained about 
95–110 mmHg and the SpO2 was maintained about 99–
100% and EtCO2 was maintained about 29-32mmHg. 
When the operation was finished, all anesthetic 
medications were stopped. While ventilating with 
100% oxygen, the patient was allowed to recover the 
responsiveness to the verbal instruction, such as 
spontaneous respiration, clenching fist, and opening 
her eyes. Fifteen mg of pyridostigmine and 0.4mg of 
glycopyrrolate were administered to reverse the 
neuromuscular blocking agents. After 3 minutes, the 
patient was extubated. The patient recovered from 
general anesthesia in the post anesthetic care unit 
(PACU) for 30 minutes and transferred to the general 
ward. The operation duration was 2 hours and 40 
minutes, and the anesthetic duration was 3 hours. Total 
fluid input was 900ml of Ringer’s lactate, and the urine 
amount was not measured. During the operation, the 
transfusion was not given to the patient as the 
estimated blood loss was below 100ml. 
 
Case 3 
A 77-year-old female patient (height: 165 cm; weight: 
65 kg) was admitted for femur neck fracture and 
scheduled for bipolar hip joint arthroplasty. The patient 
had a history of hypertension and had an operation in 
the lumbar regions 10 years ago. In the preoperative 
evaluations, pericardial effusion was detected in the 
chest computed tomography and D-dimer level and 
erythrocyte sedimentation rate(ESR) were elevated 
(17.33μg/ml, normal range: <0.50 μg/ml; ESR: 
64mm/hr). There were no abnormalities in other 
laboratory test results (Table1) and 
electrocardiography. Due to the patient’s request, the 
operation was performed under general anesthesia. The 
patient entered the operating room without 
premedication and was monitored with NIBP, ECG 
andSpO2. Pre-oxygenation with 100% (flow rate: 
10L/min) oxygen was applied for 2 minutes. Sixty mg 
of lidocaine, 100mg of propofol and 50 mg (0.82 
mg/kg) of rocuronium were injected for general 
anesthesia. In 3 minutes, the patient was intubated. 
After intubation, the esophageal body temperature 
probe was inserted and the esophageal body 
temperature was measured to be 36.7–37.3℃. The 
anesthesia was maintained with N2O/O21.0 L/min 
(FiO2 0.5) + desflurane6.0–8.0 volume% using a low 
flow anesthesia technique. The skin preparation and 
surgical drape were done and the operation was started 
about 20 minutes after the induction of anesthesia. A 
spontaneous respiration pattern was observed in the 
capnography 30 minutes after the induction of 
anesthesia, so 20 mg of rocuronium was administered. 
Thirty minutes later, a recovery sign of spontaneous 
respiration was observed in the capnography, and the 
neuromuscular function assessment device (TOF watch 
EX, Organon Ltd., Ireland) was applied. The train of 
four (TOF) showed T3 count, so 20 mg of rocuronium 
was additionally administered. Soon after, there was no 
TOF response and the capnography showed controlled 
mechanical ventilation (Fig. 1A). Twenty minutes later, 
the clefts in plateau portion of capnography (Fig. 1B) 
was observed, but no TOF response was observed in 
TOF monitor. After another 20 minutes, the 
spontaneous respiration pattern was observed in the 
capnography, and T1 and T2 counts were observed in 
the TOF monitors (Fig. 1C). After the clefts occurred 
in the plateau portion of the capnography along with 
the diaphragm movement, about 10–15 minutes were 
required to have the T1 count in the TOF monitor. 
Although an abnormality was observed in the plateau 
portion of the capnography, SpO2 and EtCO2 level 
were maintained within the normal range(SpO2: 99-
100%; EtCO2: 29-32 mmHg), and the anesthetic depth 
and vital signs were stably maintained. Ten minutes 
later, the operation was finished and anesthetic 
medications were stopped. While ventilating with 
100% oxygen, TOF count of 2 and 3 were 
consecutively observed within 1 minute, so 120 mg 
(2mg/kg) of sugammadex was administered. After 3 
minutes, TOF ratio was recovered to 1.0, and the 
patient was able to open her eyes and mouth, take deep 
breathing and respond to verbal instruction. The patient 
was extubated, recovered from general anesthesia in 
the PACU for an hour and transferred to the general 
ward. The operation duration was 1 hours and 45 
minutes, and the anesthetic duration was 2 hours and 
30 minutes. The total fluid input was 300 ml Ringer’s 
lactate and 700 ml plasmalyte A. During the operation, 
blood loss was estimated to be below 300 ml and urine 
output was estimated to be 50 ml.  
DISCUSSION 
 
The neuromuscular blocking agents is widely used for 
the general anesthesia because of easiness of airway 
intubation, limited patient movement during the 
operation, reduced use of other anesthetic agents, and it 
is one of the major drugs in the general anesthesia. The 
resistance to these neuromuscular blocking agents is 
common in the cases of burns, immobilization, 
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denervation, infectious diseases. The patients 
administered with medications for anticonvulsant 
therapy such as corticosteroids, phenytoin and 
carbamazepine are said to have resistance to the 
neuromuscular blocking agents due to the interaction of 
the medications. [3,4] However, a large amount of the 
neuromuscular blocking agents was used in these cases 
because of a much shortened action duration of the 
neuromuscular blocking agents, even though the 
patients did not have any medications that may have 
interaction or any underlying diseases that have 
resistance to neuromuscular blocking agents. In 
particular, it is important to not only select the 
appropriate neuromuscular blocking agents but also 
monitor the neuromuscular function, as there may be a 
specific response to individual differences. [6] For the 
endotracheal intubation during the induction of 
anesthesia, NMBAs are administered at least twice as 
much as ED95.The ED50 of rocuronium is 0.147mg/kg 
and the ED95 of rocuronium is 0.305 mg/kg.  
Intubation dose of rocuronium is0.6–0.9 mg/kg, and 
the duration of clinical action is about 40–50 minutes. 
To maintain this, rocuronium is administered at a dose 
of 0.1 mg/kg. [7]  In the above three cases, rocuronium 
for the endotracheal intubation was administered at 
0.82–0.83 mg/kg, but a spontaneous respiration due to 
a diaphragm movement was observed at 30–40 
minutes. Despite the maintenance dose was 
administered at 0.2–0.4 mg/kg, which is higher dose 
than usual maintenance dose, a spontaneous respiration 
was observed within 15 to 30 minutes. In the first case, 
there was no unusualness except 5mg of terazosin due 
to patient’s underlying disease, benign prostate 
hyperplasia, and smoking. In patients who smoke more 
than 10 cigarettes a day, approximately 25% more of 
the dose is required to maintain 90–98% of the 
neuromuscular block for 60 minutes in vecuronium, a 
non-depolarizing neuromuscular blocking agents 
similar torocuronium.[8] However, in this case, more 
than twice of the usual maintenance dose of 
rocuronium was administered even though the patient 
only smoke 1/2–3/4 pack/ day, and this cannot be 
simply explained by smoking alone. Furthermore, as 
the systolic blood pressure was decreased to 80 mmHg 
after 1 hour of being in a supine position, ephedrine 
and phenylephrine were administered to increase the 
blood pressure, but did not react to maintain an 
effective blood pressure. The blood pressure was 
maintained by administering norepinephrine. The 
action duration of rocuronium may have been 
shortened as ephedrine and phenylephrine promoted 
the expression by increasing the cardiac output, and 
norepinephrine caused hemodynamic effects and 
increased cardiac output. [9].It has been reported that 
the action expression time of rocuronium is shortened 
when phenylephrine, an alpha-adrenergic agonist, is 
administered. [10] In the case 1, the patient was being 
administered with ephedrine, phenylephrine and 
norepinephrine due to the hemodynamic instability and 
smoking, and with alpha-adrenergic antagonist for the 
treatment of benign prostate hyperplasia. It is thought 
to be also important to consider whether these 
medications can affect rocuronium. In the second case, 
hyperthyroidism and pregnancy may be factors 
affecting the neuromuscular blocking agents. When the 
patient have hyperthyroidism, metabolic rates are 
increased, leading to changes such as hypertension, 
tachycardia, increased cardiac output, and etc. These 
factors may affect the neuromuscular blocking agents. 
It is reported that the expression and the action duration 
of rocuronium is reduced by approximately 25–50% 
when the free T3 and the free T4 values are 
significantly higher in the patient’s preoperative 
thyroid function tests.[11] Pregnancy can affect the 
neuromuscular blocking agents due to increased body 
weight, body fluid, blood volume and distribution 
volume in the body, and increased glomerular filtration 
rate. It is known that the action duration of 
rocuroniumin the pregnant women is not different from 
that in non-pregnant women or may be even longer in 
the second trimester. This is because, while rocuronium 
is metabolized in the liver, the blood flow is increased 
in the early pregnancy, but the blood flow is reduced 
by 20% in the second trimester of the pregnancy, 
resulting in a slowed metabolic rate and a longer 
duration of action. [12,13] In the case 2, even though the 
history of hyperthyroidism and pregnancy (26 weeks of 
gestation) were the conflicting factors with 
neuromuscular blocking agents, it took less time for the 
neuromuscular blocking agents to act. This may be 
presumed to be that the patient’s metabolic rate may 
have been still elevated because the duration of the 
normal thyroid function was short as 2 months 
although the free T4 level was reduced to the normal 
range due to hyperthyroidism, and the patient decided 
to have an operation as fatigue, throbbing and burning 
symptoms persisted.[14-15] These reasons may have 
contributed to the shortened action time of the 
neuromuscular blocking agents. In the third case, a 
small amount of pericardial effusion was observed in 
the thoracic computed tomography, but not in the 
transthoracic echocardiography. There was no specific 
finding other than elevation of pre-operative D-dimer, 
and the patient did not have specific history other than 
taking antihypertensive drugs for the hypertension. 
Moreover, there was no specific symptom other than 
having an upper limit of the body temperature 
measured in the lower esophagus (37.3°C) at the 
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beginning of the operation, which can be predicted to 
be a mild fever. It is reported that the plasma clearance 
is increased by 11.3% in the neuromuscular blocking 
agents whenever the body temperature is decreased by 
1°C, and it is known that there is a difference in the 
action duration of the neuromuscular blocking agents 
according to body temperature. [14,15]However, the body 
temperature of 37.3°C is difficult to be considered as a 
high temperature outside the normal body temperature 
range, and there is a possibility that the action duration 
of the neuromuscular blocking agents to be shortened, 
but it is a unique point that the action duration was 
excessively reduced than the known action time as in 
this case. The patient's increased erythrocyte 
sedimentation rate(ESR)of 64 mm/h may suggest that 
the possibility of reduced effect of the neuromuscular 
blocking agents by increased metabolic rate due to 
inflammation reaction or infection. Like in the case 3, 
there was no actual change upon the train of four in the 
adductor pollicis muscle despite a change that could 
predict the restoration of a spontaneous respiration with 
the changes in the capnography was observed. It is 
predicted that this is due to the difference in the 
response to the neuromuscular blocking agents of the 
diaphragm and adductor pollicis muscle.[1]  In fact, the 
results of the neuromuscular monitoring and the 
changes in the capnography did not match. In the 
results of the authors' monitoring in the case 3, the T1 
count began to appear in the train of four watches after 
a significant change in the carbon dioxide curve 
(Fig.1C).A fault in these three cases is that the 
neuromuscular monitoring devices such as TOF were 
not used in the case 1 and 2. Of course, the recovery of 
the spontaneous respiration can be predicted through 
the capnography, and the degree of reversal of the 
neuromuscular block can be estimated, but using the 
neuromuscular monitoring device would enable a more 
accurate judgment by assessing the reversal of the 
neuromuscular block in particular and allowing 
numerically express the effect of the neuromuscular 
blocking agents. In addition, as rocuronium used in 
these cases was a generic drug,rocumeron®(Ilsung 
pharmaceuticals Co., Seoul, Korea), problems that may 
have occurred during the drug manufacturing processor 
problem of reduced drug potency compared to the 
original drug should be considered at one point. 
However, considering that other patients who were 
administered with rocuronium with the identical serial 
number did not have problems, it can be inferred that 
there was no problem with the drug potency or the drug 
activity. Third, the susceptibility to the neuromuscular 
blocking agents may be different in each patient. As 
these differences may be present without any specific 
disease or abnormality, using a direct neuromuscular 
monitoring device would allow to confirm a more 
accurate change in the use of neuromuscular blocking 
agents.[6] The neuromuscular blocking agents are one 
of the most commonly used drugs in the general 
anesthesia. Even though many things, such as drugs, 
patient’s accompanying disease, patient’s condition, or 
genetic factors, are known to interact with the 
neuromuscular blocking agents, it is predicted that 
many factors are yet to be discovered. By experiencing 
and presenting the patients where cardiogenic drug 
such as vasopressors, smoking, hyperthyroidism, or 
mild fever as in these cases are predicted to affected in 
the shortened duration of action, the resistance of the 
neuromuscular blocking agents that is seen in few 
cases and is not fully understood, needs to be carefully 
studied. Furthermore, when using the neuromuscular 
blocking agents, the neuromuscular monitoring devices 
should be applied together at initial monitoring to 
detect these changes early and to take appropriate 
action.   
 
Table 1: Results of Preoperative Laboratory Test 
  Case I Case II Case III 
Pre-op Post-op Pre-op Post-op Pre-op Post-op 
Hb (g/dl) 13.3 11.3 11.7 9.5 12.5 11.1 
Hct (%) 41.2 33.8 34.4 28.5 36.1 32.8 
Plt (x103/ul) 264 298 210 178 302 264 
PT (INR) 0.94 - 1.01 - 1.02 - 
APTT (sec) 30.3 - 28.0 - 30.2 - 
Calcium (mg/dl) 8.0 8.1 8.1 7.1 8.2 8.0 
Glucose (mg/dl) 172 97 81 110 175 118 
Creatinine (mg/dl) 0.74 0.58 0.27 0.29 0.52 0.46 
Sodium (mEq/L) 138.0 137.0 136.0 136.0 137.0 135.0 
Potassium (mEq/L) 3.9 3.7 3.6 3.2 3.7 4.1 
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Chloride (mEq/L) 105 104 106 106 101 102 
Total bilirubin (mg/dl) 1.07 1.22 0.48 0.45 0.98 0.70 
Table 2: Results of Arterial Blood Gas Analysis at 100 and 140 Minutes after Induction of Anesthesia 
 
 After 100 min (FiO2 : 50%) After 140 min. (FiO2 : 70%) 
pH  7.40 7.39 
PaCO2 (mmHg) 37 39 
PaO2 (mmHg) 56 71 
SaO2 (%) 89 94 
Sodium (mEq/L) 138 38 
Potassium (mEq/L) 3.1 3.6 
Ionized Calcium (mg/dl) 3.89 4.13 
Glucose (mg/dl) 148 246 
Hb (g/dl) 12.9 13.8 
Hct. (%) 38 41 
 
Table 3: Results of Thyroid Function Test 
 
 5/29 8/9 8/17 9/5 9/7 9/10 9/13 
TSH < 0.04 < 0.04 < 0.04 < 0.04 < 0.04 < 0.04 < 0.04 
fT4 2.9 1.6 1.5 1.3 1.4 1.1 0.86 
TSH-R-Ab > 40.0 35.4 - - - - - 
PTH-intact - - - - 35.4 25.2 - 
 
 
Figure 1: These figures show the capnography during surgery.  (A) The capnography after rocuronium injection via 
intravenous line.  (B) Clefts were observed in the plateau portion of the capnography when the action of muscle 
relaxants is subsided and the sign of spontaneous respiration returns.  (C) The capnography when T1 is observed in 
the TOF monitor. 
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